Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice.

Enrico LongatoBarbara Di CamilloGiovanni SparacinoLara TramontanAngelo AvogaroGian Poalo Fadini

Published in: Cardiovascular diabetology (2020)

Patients initiating a GLP-1RA in clinical practice had better cardiovascular outcomes than similar patients who initiated a DPP-4i. These data strongly confirm findings from cardiovascular outcome trials in a lower risk population.

Keyphrases

clinical practice
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
rheumatoid arthritis
prognostic factors
electronic health record
big data
patient reported outcomes
interstitial lung disease